Ketamine IV for the prevention of depression in the elderly: new data

Published Date: 13 Mar 2023

Intravenous (IV) ketamine is effective in adults resistant to depression. The response was similar to that seen in younger patients, two new studies show.

Read Full News

Latest News

First-in-Class Tx for Dravet Syndrome Shows Early Success

A first-in-class gene-regulating therapy cut seizures by up to 91% in children with Dravet syndrome in extension studies, raising hopes for a disease-modifying treatment.

Work Disability Risk Can Persist Years After TBI

Traumatic brain injury is linked to a persistently increased risk for work disability irrespective of the severity of the trauma, a new cohort study shows.

Could Red Light Help Tackle Resistant Klebsiella Pneumoniae?

Researchers report that photodynamic therapy increases antibiotic penetration and disrupts resistance mechanisms in laboratory strains.

Gut Infection Disease Care: From GP Clinics to Hospitals

An infectious intestinal disease episode can be noted in both primary care and hospital admissions, with children and older adults having higher odds of admissions during a primary care episode.

Booster Shots Reduce Risk for Severe COVID Outcomes

According to a study of more than 5.5 million adults aged 50 years or older, vaccination with the bivalent BA.1 mRNA booster lowers risks for COVID-related hospitalisation and death.

Unmarried Older Adults Face Increased Humerus Fracture Risk

Older adults of Norwegian origin and those who are unmarried face an increased risk for humerus fractures, with a higher incidence seen in winter than in summer and more injuries occurring outdoors.

Todays Updates

Neoadjuvant GOLP Boosts Event-Free Survival in Liver Cancer

A phase 2/3 trial evaluates the efficacy and safety of neoadjuvant therapy with gemcitabine-oxaliplatin, lenvatinib, and toripalimab in patients with high-risk intrahepatic cholangiocarcinoma.

Risk Factors Driving Severe Maternal Morbidity in the US

Hypertensive disorders of pregnancy, chronic hypertension, and obesity are the primary risk factors for severe maternal morbidity.

CUD, Depression Share Bidirectional Link

Cannabis use disorder has a bidirectional and clinically meaningful association with major depressive disorder, new research suggests.

Medicaid Expansion Tied to Pancreatic Cancer Survival

A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic cancer.

Can Upadacitinib Improve Sleep Quality in Patients With RA?

Upadacitinib may improve self-reported sleep quality at 3 months in patients with rheumatoid arthritis, with sustained benefits seen over the long term.

Novel Drug Duo Preserves Bladder in Muscle-Invasive Cancer

Approximately 40% of patients with muscle-invasive bladder cancer achieve a clinical complete response after neoadjuvant sacituzumab govitecan plus pembrolizumab, the SURE-02 trial finds.

Exploring Whether GLP-1 Medications May Cause Sinusitis

Research is limited, but what has been done shows a possible connection.

Todays Updates

Neoadjuvant GOLP Boosts Event-Free Survival in Liver Cancer

A phase 2/3 trial evaluates the efficacy and safety of neoadjuvant therapy with gemcitabine-oxaliplatin, lenvatinib, and toripalimab in patients with high-risk intrahepatic cholangiocarcinoma.

Risk Factors Driving Severe Maternal Morbidity in the US

Hypertensive disorders of pregnancy, chronic hypertension, and obesity are the primary risk factors for severe maternal morbidity.

CUD, Depression Share Bidirectional Link

Cannabis use disorder has a bidirectional and clinically meaningful association with major depressive disorder, new research suggests.

Medicaid Expansion Tied to Pancreatic Cancer Survival

A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic cancer.

Can Upadacitinib Improve Sleep Quality in Patients With RA?

Upadacitinib may improve self-reported sleep quality at 3 months in patients with rheumatoid arthritis, with sustained benefits seen over the long term.

Novel Drug Duo Preserves Bladder in Muscle-Invasive Cancer

Approximately 40% of patients with muscle-invasive bladder cancer achieve a clinical complete response after neoadjuvant sacituzumab govitecan plus pembrolizumab, the SURE-02 trial finds.

Exploring Whether GLP-1 Medications May Cause Sinusitis

Research is limited, but what has been done shows a possible connection.

Latest News

A first-in-class gene-regulating therapy cut seizures by up to 91% in children with Dravet syndrome in extension studies, raising hopes for a disease-modifying treatment.

Traumatic brain injury is linked to a persistently increased risk for work disability irrespective of the severity of the trauma, a new cohort study shows.

Researchers report that photodynamic therapy increases antibiotic penetration and disrupts resistance mechanisms in laboratory strains.

An infectious intestinal disease episode can be noted in both primary care and hospital admissions, with children and older adults having higher odds of admissions during a primary care episode.

According to a study of more than 5.5 million adults aged 50 years or older, vaccination with the bivalent BA.1 mRNA booster lowers risks for COVID-related hospitalisation and death.

Older adults of Norwegian origin and those who are unmarried face an increased risk for humerus fractures, with a higher incidence seen in winter than in summer and more injuries occurring outdoors.

News All Time

Cereulide Found in Recalled Baby Formula, Switzerland Says

Traces of a toxin that can cause ⁠nausea and vomiting were found in two types ⁠of infant formula recalled by France's Danone ⁠earlier this month.

EU: Cereulide Exposure Risk Low After Baby Formula Recalls

The risk of infants being exposed to baby formula contaminated with the cereulide toxin is ⁠now low following recalls across several countries, European authorities say.

US CDC Cancels February Vaccine Adviser Meeting; no New One Set Yet

A U.S. vaccine advisory committee meeting scheduled for later this month by the Centers for Disease Control and Prevention will not be held, with no ⁠new dates announced,...

Updates in Complicated UTI Classification and Treatment

Updates in Complicated UTI Classification and Treatment

Here Today, Safe Tomorrow: Accelerating HIV Prevention With Same-Day and Rapid PrEP Initiation

Here Today, Safe Tomorrow: Accelerating HIV Prevention With Same-Day and Rapid PrEP Initiation

Accelerating HIV Prevention in Primary Care Settings

Accelerating HIV Prevention in Primary Care Settings

Integrating Same-Day or Rapid PrEP Initiation With Substance Use Treatment to Support Holistic Harm Reduction

Integrating Same-Day or Rapid PrEP Initiation With Substance Use Treatment to Support Holistic Harm Reduction

Bringing Rapid PrEP to the Frontlines in Community Pharmacies

Bringing Rapid PrEP to the Frontlines in Community Pharmacies

My Child Was in an Active Shooter Lockdown. This Horror Will Come for Many of Us.

Here are lessons learned about a reality even physicians aren't trained for

Deaths Prompt Clinical Trial Hold; $8,000 'Scorpion' Bill; The Next COVID Vaccine

Health news and commentary gathered by MedPage Today staff

Doctors vs Advanced Practice Providers: A False Fault Line in Medicine

They are teammates working in a system that pits them against each other

Call 911 or Risk Losing the Baby? Raids Force Some Immigrants to Avoid Care.

Immigration sweeps add to the healthcare barriers that some already face

Coffee, Chocolate, and Cellular Aging; Medical Aircraft Crash Kills 5; AAP Sues HHS

Health news and commentary gathered by MedPage Today staff

Are We All as Miserable as the Doctors on 'The Pitt'?

Why some people choose careers that haunt them

After Judge's Ruling, HHS Can Resume Sharing Medicaid Data With Deportation Officers

But the decision strictly limits the scope of data that can be shared

Is Recovery-Oriented, Involuntary Psychiatric Treatment Possible?

A roadmap for responsible, ethical, and individualized intervention

Recommended News For You

Unified Neuro/Psych Residency Program: New Proposal.

Three-Drug Regimens Make Case for a Role in Untreated and Relapsed/Refractory CLL

"Unusual" Cancers Following Pandemic; Triumph in TNBC; Clinical Trial Interrupted by Shortage.

According to the Lancet, having cancer and VTE at the same time increases mortality risk.

Report: Breast cancer mortality continues three decade decline, but steeper increases in incidence for some women

Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancer

New protein target discovered for childhood medulloblastomas

Recommended Articles For You

Next-Gen Cancer Therapies: Radiopharmaceuticals, Immuno-Oncology, and Biologic Breakthroughs 

Navigating the Complexity of Peritoneal Carcinomatosis: A Guide for Patients and Caregivers 

Pediatric Oncology at the Cutting Edge: From Early Diagnosis to Lifesaving Therapies 

A Comprehensive Guide to Using an ABG Calculator for Accurate Diagnosis 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Scientists discover the 'roadmap' that aggressive cancer uses to spread

2.

Patients with head and neck cancer who cannot receive cisplatin now have new hope.

3.

Who Bears the Cost of "Forever Chemical" Cleanup?

4.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

5.

An Eye Surgeon's Unexpected Discovery of the "Before and After".

1.

A New Hope: Exploring the Benefits of Exenteration for Cancer Patients

2.

Bispecific Antibodies in DLBCL & Myeloma: Clinical Insights for Physicians

3.

Understanding Abemaciclib: A Breakthrough Treatment for Breast Cancer 

4.

Understanding the Importance of Knowing Your MCV Normal Range

5.

Beyond the Brain Fog: The Complex Neurological Challenges and Therapeutic Advances

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II

2.

Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment

3.

Navigating the Complexities of Ph Negative ALL - Part XIII

4.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot